应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09939 开拓药业-B
已收盘 10-02 16:08:34
1.400
+0.230
+19.66%
最高
1.400
最低
1.170
成交量
721.30万
今开
1.170
昨收
1.170
日振幅
19.66%
总市值
6.26亿
流通市值
6.26亿
总股本
4.47亿
成交额
916.94万
换手率
1.61%
流通股本
4.47亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
礼来(LLY)斥资45亿美元在印第安纳州建设新医药工厂 预计2027年底投入运营
金吾财讯 · 19:54
礼来(LLY)斥资45亿美元在印第安纳州建设新医药工厂 预计2027年底投入运营
港股异动 | 医药股强势上攻 CRO方向领涨 泰格医药(03347)一度升30%
智通财经 · 13:45
港股异动 | 医药股强势上攻 CRO方向领涨 泰格医药(03347)一度升30%
同源康医药-B盘中异动 大幅跳水5.32%报30.250港元
市场透视 · 10:47
同源康医药-B盘中异动 大幅跳水5.32%报30.250港元
国泰君安:港股未来走势以向上为主 利率敏感型行业股价弹性更大
美港电讯 · 10:23
国泰君安:港股未来走势以向上为主 利率敏感型行业股价弹性更大
【港股通】泰格医药(03347)涨12.47% 拟以1.4亿元人民币收购观合医药约40%股权
金吾财讯 · 09:53
【港股通】泰格医药(03347)涨12.47% 拟以1.4亿元人民币收购观合医药约40%股权
开拓药业-B盘中异动 股价大涨5.13%报1.230港元
市场透视 · 09:33
开拓药业-B盘中异动 股价大涨5.13%报1.230港元
10月1日老百姓涨停分析:健康中国,腾讯概念股,医药概念热股
证券之星 · 10-01 15:26
10月1日老百姓涨停分析:健康中国,腾讯概念股,医药概念热股
10月1日亚泰集团涨停分析:疫苗,医药,保健品概念热股
证券之星 · 10-01 15:26
10月1日亚泰集团涨停分析:疫苗,医药,保健品概念热股
10月1日济川药业涨停分析:健康中国,口腔,医药概念热股
证券之星 · 10-01 15:26
10月1日济川药业涨停分析:健康中国,口腔,医药概念热股
10月1日新里程涨停分析:互联网医疗,医药,民营医院概念热股
证券之星 · 10-01 15:25
10月1日新里程涨停分析:互联网医疗,医药,民营医院概念热股
10月1日辽宁成大涨停分析:疫苗,医药,油服概念热股
证券之星 · 10-01 15:25
10月1日辽宁成大涨停分析:疫苗,医药,油服概念热股
10月1日小方制药涨停分析:医药概念热股
证券之星 · 10-01 15:23
10月1日小方制药涨停分析:医药概念热股
10月1日益丰药房涨停分析:互联网医疗,健康中国,医药概念热股
证券之星 · 10-01 15:22
10月1日益丰药房涨停分析:互联网医疗,健康中国,医药概念热股
泰格医药1.4亿回收观合医药股权,宣告医学检验业务IPO告吹
经济观察网 · 10-01 06:49
泰格医药1.4亿回收观合医药股权,宣告医学检验业务IPO告吹
【ETF动向】9月30日平安医药及医疗器械创新ETF基金涨10.15%,份额减少2亿份
证券之星 · 10-01 06:31
【ETF动向】9月30日平安医药及医疗器械创新ETF基金涨10.15%,份额减少2亿份
万春医药上涨3.18%,报2.27美元/股
金融界 · 10-01 00:49
万春医药上涨3.18%,报2.27美元/股
牛回速归!超6成私募建议重仓或满仓过节!消费、医药板块获关注
私募排排网 · 09-30 19:41
牛回速归!超6成私募建议重仓或满仓过节!消费、医药板块获关注
闻泰医药公布B轮融资,投资方为深创投
证券之星 · 09-30 19:32
闻泰医药公布B轮融资,投资方为深创投
9月30日鲁泰A涨7.39%,安信消费医药股票基金重仓该股
证券之星 · 09-30 17:54
9月30日鲁泰A涨7.39%,安信消费医药股票基金重仓该股
9月30日西山科技涨13.58%,申万菱信医药先锋股票A基金重仓该股
证券之星 · 09-30 17:46
9月30日西山科技涨13.58%,申万菱信医药先锋股票A基金重仓该股
暂无数据
公司概况
公司名称:
开拓药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。
发行价格:
--
{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":1.4,"timestamp":1727856514037,"preClose":1.17,"halted":0,"volume":7213000,"delay":0,"floatShares":447499600,"shares":447499600,"eps":-2.7314055,"marketStatus":"已收盘","marketStatusCode":5,"change":0.23,"latestTime":"10-02 16:08:34","open":1.17,"high":1.4,"low":1.17,"amount":9169395,"amplitude":0.196581,"askPrice":1.4,"askSize":137000,"bidPrice":1.38,"bidSize":14500,"shortable":0,"etf":0,"ttmEps":-2.363906121853111,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727919000000},"adr":0,"listingDate":1590076800000,"adjPreClose":1.17,"openAndCloseTimeList":[[1727832600000,1727841600000],[1727845200000,1727856000000]],"volumeRatio":3.650304,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939/tweets","defaultTab":"tweets","newsList":[{"id":"2472544816","title":"礼来(LLY)斥资45亿美元在印第安纳州建设新医药工厂 预计2027年底投入运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2472544816","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472544816?lang=zh_cn&edition=full","pubTime":"2024-10-02 19:54","pubTimestamp":1727870056,"startTime":"0","endTime":"0","summary":"金吾财讯 | 礼来(LLY)宣布了一项重大投资,在印第安纳州建立一个全新的医药工厂,投资额高达45亿美元。这一举措是为了促进药物生产的创新,并且支持临床试验药物的生产。该工厂预计将在2027年年底之前开始运营。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NGRhYzM3NGFmNjhkZjU2YzllYzhmYTA3NGMxMjcyMzM2MzUzOA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGRhYzM3NGFmNjhkZjU2YzllYzhmYTA3NGMxMjcyMzM2MzUzOA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"280483","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","LU0471298694.HKD","LU0289739699.SGD","LU0708995401.HKD","LU0689472784.USD","LU0006306889.USD","LU1280957306.USD","IE00BK4W5M84.HKD","IE00BK4W5L77.USD","LU0672654240.SGD","BK4588","LU1551013342.USD","LU1023059063.AUD","BK4007","LU0238689110.USD","IE00BJLML261.HKD","LU0106261372.USD","BK4581","GB00BDT5M118.USD","LU1061106388.HKD","BK4585","BK1574","LU0109391861.USD","09939","IE0004445239.USD","LU1057294990.SGD","LU0417517546.SGD","LU0943347566.SGD","LU0820561909.HKD","LU0061475181.USD","LU0354030511.USD","LU0354030438.USD","BK4516","LU0094547139.USD","LU0882574055.USD","LU0079474960.USD","IE00B1BXHZ80.USD","LU0256863811.USD","BK1515","LU0320765059.SGD","LU0256863902.USD","LLY","IE0002141913.USD","LU1035775433.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4533","BK1161","LU0122379950.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2472921596","title":"港股异动 | 医药股强势上攻 CRO方向领涨 泰格医药(03347)一度升30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472921596","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472921596?lang=zh_cn&edition=full","pubTime":"2024-10-02 13:45","pubTimestamp":1727847905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医药股强势上攻,CRO方向领涨,泰格医药一度涨近30%。截至发稿,泰格医药涨19.7%,报48港元;药明康德涨12%,报61.15港元;荣昌生物涨11.35%,报19.04港元;药明生物涨10.4%,报19.32港元。消息面上,受国新办新闻发布会及中共中央政治局会议的超预期政策影响,医药股近期随大盘强势上攻。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1720050803.USD","LU2242644610.SGD","LU0181495838.USD","LU0052750758.USD","LU1820825898.SGD","LU0417516902.SGD","BK1161","LU0359201612.USD","BK1521","LU0359202008.SGD","LU2125910500.SGD","LU0456846285.SGD","159938","LU0320764599.SGD","BK1515","LU0979878070.USD","LU0043850808.USD","LU2039709279.SGD","LU1046422090.SGD","02269","02359","LU0823426308.USD","LU1969619763.USD","09995","300347","LU0516423174.USD","LU0708995583.HKD","BK1610","LU1146622755.USD","LU0588546209.SGD","LU0819121731.USD","BK1141","LU0856984785.SGD","LU0417516738.SGD","SG9999002562.SGD","LU1880383366.USD","LU1794554557.SGD","LU0326950275.SGD","BK1574","03347","LU0348735423.USD","LU0140636845.USD","LU0823426480.USD","09939","LU2328871848.SGD","SG9999002463.SGD","LU1242518931.SGD","BK0216","LU0516422952.EUR","BK0028"],"gpt_icon":1},{"id":"2472789565","title":"同源康医药-B盘中异动 大幅跳水5.32%报30.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472789565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472789565?lang=zh_cn&edition=full","pubTime":"2024-10-02 10:47","pubTimestamp":1727837229,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘10时47分,同源康医药-B股票出现波动,股价大幅下挫5.32%。截至发稿,该股报30.250港元/股,成交量3.05万股,换手率0.02%,振幅2.97%。资金方面,该股资金流入75.42万港元,流出18.5475万港元。同源康医药-B股票所在的生物技术行业中,整体跌幅为1.00%。其相关个股中,泰格医药、加科思-B、贝康医疗-B涨幅较大,振幅较大的相关个股有创胜集团-B、北海康成-B、泰格医药,振幅分别为37.50%、26.67%、25.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021047099719de09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021047099719de09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1515","02410","BK1574"],"gpt_icon":0},{"id":"2472568428","title":"国泰君安:港股未来走势以向上为主 利率敏感型行业股价弹性更大","url":"https://stock-news.laohu8.com/highlight/detail?id=2472568428","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472568428?lang=zh_cn&edition=full","pubTime":"2024-10-02 10:23","pubTimestamp":1727835834,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09979","HK0000934320.USD","159792","BK0184","BK1161","MCHmain","ZNmain","BK1148","HSCEI","BK1147","159938","02833","BK0201","MHImain","BK1515","07226","02611","601211","HSTECH","HSImain","BK0183","HSI","TNmain","YANG","UBmain","BK0012","BK0276","ZFmain","BK1574","160636","BK0188","513600","ZTmain","09939","ZBmain","HHImain","BK1564","BK0028"],"gpt_icon":0},{"id":"2472557954","title":"【港股通】泰格医药(03347)涨12.47% 拟以1.4亿元人民币收购观合医药约40%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2472557954","media":"金吾财讯","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472557954?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:53","pubTimestamp":1727833995,"startTime":"0","endTime":"0","summary":"金吾财讯 | 泰格医药(03347)盘初向好,截至发稿,涨12.47%,报45.1港元,成交额2139万港元。需要注意的是,该股在过去6个交易日涨幅达68%。消息面上,日前公司公布,拟以现金方式受让迪安诊断和苏州瀛凯合计持有的观合医药40.5650%股权,购买价格合计为人民币1.4亿元。本次交易完成后,公司及全资子公司嘉兴欣格将合计直接及间接持有观合医药72.8169%股权,观合医药将纳入公司合并报表范围。本次交易构成关联交易。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/NDRmNzljZmMyYzdlZTk1NTA3MWQyNTAwMjM0Njg4MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NDRmNzljZmMyYzdlZTk1NTA3MWQyNTAwMjM0Njg4MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1945158","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1576","159938","BK1161","02359","LU1820825898.SGD","BK1574","BK1141","BK1583","BK0077","BK0216","BK1515","300347","HSCEI","LU1146622755.USD","09939","03347","YANG","BK0174","HSTECH"],"gpt_icon":0},{"id":"2472555797","title":"开拓药业-B盘中异动 股价大涨5.13%报1.230港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472555797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472555797?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:33","pubTimestamp":1727832803,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘09时33分,开拓药业-B股票出现波动,股价快速拉升5.13%。截至发稿,该股报1.230港元/股,成交量7.75万股,换手率0.02%,振幅5.13%。资金方面,该股资金流入8.1225万港元,流出0港元。开拓药业-B股票所在的药品行业中,整体跌幅为0.12%。其相关个股中,海王英特龙、精优药业、康龙化成涨幅较大,振幅较大的相关个股有海王英特龙、康龙化成、精优药业,振幅分别为13.04%、8.93%、6.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020933249719dcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020933249719dcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2472434883","title":"10月1日老百姓涨停分析:健康中国,腾讯概念股,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472434883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472434883?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:26","pubTimestamp":1727767612,"startTime":"0","endTime":"0","summary":"证券之星消息,老百姓10月1日涨停收盘,收盘价17.38元。该股于9点25分涨停,7次打开涨停,截止收盘封单资金为3983.71万元,占其流通市值0.3%。近5日资金流向一览见下表:该股为健康中国,腾讯概念股,医药概念热股,当日健康中国概念上涨11.49%,腾讯概念股概念上涨10.7%,医药概念上涨10.68%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1608","09939","80700","IE0032834883.USD","TCEHY","IE00BZ08YS42.EUR","IE00BPRC5H50.USD","LU0054237671.USD","IE0003851619.USD","LU0080751232.USD","IE0031814852.USD","BK1516","IE0003895053.USD","IE00B0JY6N72.USD","IE0003795394.USD","00700","HK0000306685.HKD","BK1521","BK1517","159938","BK1515","LU0048580855.USD","BK1591","IE00B067MR52.USD","HK0000306701.USD","LU0011963245.USD","IE0008368742.USD","LU0029875118.USD","IE0034224299.USD","IE00B031HY20.USD","603883","BK1161","IE00B3M56506.USD","IE00B97KM107.HKD","LU0047713382.USD","BK1589","IE00BZ08YR35.GBP","BK1531","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU0043850808.USD","LU0061477393.USD","LU0049853897.USD","IE00B0169L03.USD","IE00B29SXG58.USD","BK1586","BK1526","IE0032431581.USD","LU0072462343.USD","LU0039217434.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2472310073","title":"10月1日亚泰集团涨停分析:疫苗,医药,保健品概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472310073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472310073?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:26","pubTimestamp":1727767594,"startTime":"0","endTime":"0","summary":"证券之星消息,亚泰集团10月1日涨停收盘,收盘价1.89元。该股于9点25分涨停,未打开涨停,截止收盘封单资金为7539.15万元,占其流通市值1.23%。近5日资金流向一览见下表:该股为疫苗,医药,保健品概念热股,当日疫苗概念上涨12.92%,医药概念上涨10.68%,保健品概念上涨9.71%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0235","BK1574","600881","159938","BK0028","BK0188","BK0057","BK1515","09939","BK0112","BK0012","BK0116","BK0060","BK0139","159646","BK0074"],"gpt_icon":0},{"id":"2472348873","title":"10月1日济川药业涨停分析:健康中国,口腔,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472348873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472348873?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:26","pubTimestamp":1727767584,"startTime":"0","endTime":"0","summary":"证券之星消息,济川药业10月1日涨停收盘,收盘价31.32元。该股于9点30分涨停,31次打开涨停,截止收盘封单资金为2924.11万元,占其流通市值0.1%。近5日资金流向一览见下表:该股为健康中国,口腔,医药概念热股,当日健康中国概念上涨11.49%,口腔概念上涨10.86%,医药概念上涨10.68%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK1515","BK1574","09939","BK0012","600566","BK0077","BK1161","BK0239","BK0201","BK0028","159938","BK0188"],"gpt_icon":0},{"id":"2472731004","title":"10月1日新里程涨停分析:互联网医疗,医药,民营医院概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472731004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472731004?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:25","pubTimestamp":1727767553,"startTime":"0","endTime":"0","summary":"证券之星消息,新里程10月1日涨停收盘,收盘价2.3元。该股于9点35分涨停,未打开涨停,截止收盘封单资金为3503.39万元,占其流通市值0.46%。近5日资金流向一览见下表:该股为互联网医疗,医药,民营医院概念热股,当日互联网医疗概念上涨12.25%,医药概念上涨10.68%,民营医院概念上涨10.67%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK1209","BK1574","BK1161","BK0077","BK0028","BK0096","09939","09906","159938","002219","BK1515"],"gpt_icon":0},{"id":"2472348852","title":"10月1日辽宁成大涨停分析:疫苗,医药,油服概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472348852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472348852?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:25","pubTimestamp":1727767552,"startTime":"0","endTime":"0","summary":"证券之星消息,辽宁成大10月1日涨停收盘,收盘价11.58元。该股于9点35分涨停,3次打开涨停,截止收盘封单资金为2242.76万元,占其流通市值0.13%。近5日资金流向一览见下表:该股为疫苗,医药,油服概念热股,当日疫苗概念上涨12.92%,医药概念上涨10.68%,油服概念上涨10.06%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600739","BK0196","BK1515","159646","09939","BK0074","BK0144","BK1161","BK0250","BK1574","159938","BK0188"],"gpt_icon":0},{"id":"2472106563","title":"10月1日小方制药涨停分析:医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472106563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472106563?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:23","pubTimestamp":1727767426,"startTime":"0","endTime":"0","summary":"证券之星消息,小方制药10月1日涨停收盘,收盘价26.31元。该股于10点25分涨停,13次打开涨停,截止收盘封单资金为385.9万元,占其流通市值0.37%。近5日资金流向一览见下表:该股为医药概念热股,当日医药概念上涨10.68%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","09939","BK1515","BK1161","603207","159938"],"gpt_icon":0},{"id":"2472310646","title":"10月1日益丰药房涨停分析:互联网医疗,健康中国,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472310646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472310646?lang=zh_cn&edition=full","pubTime":"2024-10-01 15:22","pubTimestamp":1727767335,"startTime":"0","endTime":"0","summary":"证券之星消息,益丰药房10月1日涨停收盘,收盘价25.52元。该股于11点8分涨停,14次打开涨停,截止收盘封单资金为1035.68万元,占其流通市值0.03%。近5日资金流向一览见下表:该股为互联网医疗,健康中国,医药概念热股,当日互联网医疗概念上涨12.25%,健康中国概念上涨11.49%,医药概念上涨10.68%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100012128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1574","LU1064130708.USD","159938","603939","LU1064131003.USD","LU2460026573.USD","LU2148510915.USD","BK1161","09939","BK0209"],"gpt_icon":0},{"id":"2472138366","title":"泰格医药1.4亿回收观合医药股权,宣告医学检验业务IPO告吹","url":"https://stock-news.laohu8.com/highlight/detail?id=2472138366","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472138366?lang=zh_cn&edition=full","pubTime":"2024-10-01 06:49","pubTimestamp":1727736540,"startTime":"0","endTime":"0","summary":"基于此,本次交易中,泰格医药拟以现金方式受让迪安诊断和苏州瀛凯合计持有的观合医药40.565%股权,购买价格合计为人民币1.4亿元。泰格医药提出,本次交易完成后, 观合医药将作为公司临床试验全链条服务中的重要一环,能增强企业的一站式服务能力。在本次交易前,泰格医药的全资子公司嘉兴欣格就持有观合医药1900万股,持股比例为31.341%。对于观合医药IPO的动态,9月29日,泰格医药回应称,观合医药下一步的发展,还是以未来的公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-10-01/doc-incqyxsa2452253.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-01/doc-incqyxsa2452253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","BK1161","BK0216","300347","BK0174","LU1146622755.USD","BK1141","BK1576","BK1515","BK1574","LU1820825898.SGD","159938","BK0077","BK0028","09939","BK1583"],"gpt_icon":0},{"id":"2472700363","title":"【ETF动向】9月30日平安医药及医疗器械创新ETF基金涨10.15%,份额减少2亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2472700363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472700363?lang=zh_cn&edition=full","pubTime":"2024-10-01 06:31","pubTimestamp":1727735473,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日,平安医药及医疗器械创新ETF基金(516820)涨10.15%,成交额1.64亿元。当日份额减少了2亿份,最新份额为38.63亿份,近20个交易日份额减少2.3亿份。当日资金净流入9565.08万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为14.33亿元。平安医药及医疗器械创新ETF基金跟踪标的为中证医药及医疗器械创新指数,成立(2021-06-09)以来超额回报为1.29%,近一个月超额回报为-1.17%,管理人为平安基金公司,基金经理为翁欣。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100100009027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK1574","159883","159938","BK1100","BK1583","159987","BK1515","09939","09996","BK1161","09997"],"gpt_icon":0},{"id":"2472394143","title":"万春医药上涨3.18%,报2.27美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472394143","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472394143?lang=zh_cn&edition=full","pubTime":"2024-10-01 00:49","pubTimestamp":1727714949,"startTime":"0","endTime":"0","summary":"10月1日,万春医药(BYSI)盘中上涨3.18%,截至00:49,报2.27美元/股,成交4.54万美元。财务数据显示,截至2024年06月30日,万春医药收入总额100.0万美元,同比增长14.29%;归母净利润-726.2万美元,同比增长42.91%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/10/01004943691133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["09939","159938","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2471838869","title":"牛回速归!超6成私募建议重仓或满仓过节!消费、医药板块获关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2471838869","media":"私募排排网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471838869?lang=zh_cn&edition=full","pubTime":"2024-09-30 19:41","pubTimestamp":1727696470,"startTime":"0","endTime":"0","summary":"自从9月24日以来,一篮子利好资本市场、房地产市场等各方面的重大刺激性政策颁布后,A股市场连续4天上涨。其中,上证指数累涨12.32%,收复3000点;创业板指累涨23.19%,9月27日单日涨幅创下历史新高;深证成指累涨17.71%。除了国内投资者热火朝天,高盛、大摩等一众外资火速翻多,中国资产瞬间成为全球市场的焦点。针对是否...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OVtRz4-dsft5siZDZUFcHP6gxrg_E6mYH2NHfRc2TckdIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OVtRz4-dsft5siZDZUFcHP6gxrg_E6mYH2NHfRc2TckdIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240930A08IJ400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240930A08IJ400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["09939","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2471259806","title":"闻泰医药公布B轮融资,投资方为深创投","url":"https://stock-news.laohu8.com/highlight/detail?id=2471259806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471259806?lang=zh_cn&edition=full","pubTime":"2024-09-30 19:32","pubTimestamp":1727695930,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于9月26日公布的信息整理,苏州闻泰医药科技有限公司公布B轮融资,融资额未披露,参与投资的机构包括深创投。闻泰医药是一家创新医药企业,由中科院多位博士共同创立,核心团队在相关领域深耕多年,创业经验丰富。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000035959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","09939","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"2471874187","title":"9月30日鲁泰A涨7.39%,安信消费医药股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471874187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471874187?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:54","pubTimestamp":1727690055,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日鲁 泰A涨7.39%创60日新高,收盘报6.54元,换手率4.49%,成交量26.43万手,成交额1.68亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为安信消费医药股票。安信消费医药股票目前规模为1.73亿元,最新净值1.022,较上一交易日上涨4.97%,近一年下跌13.9%。安信消费医药股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000031518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","BK1574","09939","159938"],"gpt_icon":0},{"id":"2471748408","title":"9月30日西山科技涨13.58%,申万菱信医药先锋股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471748408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471748408?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:46","pubTimestamp":1727689592,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日西山科技涨13.58%创60日新高,收盘报68.0元,换手率9.63%,成交量2.42万手,成交额1.59亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为申万菱信医药先锋股票A。申万菱信医药先锋股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000031128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159938","BK1161","BK1515","BK1574","BK0251","688576"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":0.2447},{"period":"1month","weight":0.2857},{"period":"3month","weight":0.1359},{"period":"6month","weight":0.3448},{"period":"1year","weight":-0.573},{"period":"ytd","weight":-0.2822}],"compareEarnings":[{"period":"1week","weight":0.1582},{"period":"1month","weight":0.1748},{"period":"3month","weight":0.1893},{"period":"6month","weight":0.2636},{"period":"1year","weight":0.1866},{"period":"ytd","weight":0.2397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家临床阶段新药开发商,专注于研究癌症药物及其他雄激素受体(AR)相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌(mCRPC)的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.058646},{"month":2,"riseRate":0.75,"avgChangeRate":0.213088},{"month":3,"riseRate":0.25,"avgChangeRate":0.062774},{"month":4,"riseRate":0.75,"avgChangeRate":0.545629},{"month":5,"riseRate":0.5,"avgChangeRate":0.006555},{"month":6,"riseRate":0.2,"avgChangeRate":-0.08997},{"month":7,"riseRate":0.6,"avgChangeRate":0.020249},{"month":8,"riseRate":0.2,"avgChangeRate":-0.059234},{"month":9,"riseRate":0.2,"avgChangeRate":-0.170155},{"month":10,"riseRate":0.25,"avgChangeRate":-0.084422},{"month":11,"riseRate":0.75,"avgChangeRate":0.089012},{"month":12,"riseRate":0.25,"avgChangeRate":-0.241375}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}